Cleared Special

K051374 - CARDIODRIVE CATHETER ADVANCEMENT SYSTEM (FDA 510(k) Clearance)

Jun 2005
Decision
28d
Days
Class 2
Risk

K051374 is an FDA 510(k) clearance for the CARDIODRIVE CATHETER ADVANCEMENT SYSTEM. This device is classified as a Wire, Guide, Catheter (Class II - Special Controls, product code DQX).

Submitted by Stereotaxis, Inc. (Saint Louis, US). The FDA issued a Cleared decision on June 23, 2005, 28 days after receiving the submission on May 26, 2005.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1330.

Submission Details

510(k) Number K051374 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 26, 2005
Decision Date June 23, 2005
Days to Decision 28 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code DQX — Wire, Guide, Catheter
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.1330